PHARMACEUTICAL COMPOSITION, CRYSTAL FORM OF PROTHIOCONAZOLE, PREPARATION METHOD AND APPLICATION THEREOF

WIPO Patent Application WO/2021/022604

A1

Disclosed is a pharmaceutical composition, a crystal form of prothioconazole, a preparation method, and an application thereof, belonging to the field of bactericide. The X-ray powder diffraction pattern of the crystal form of prothioconazole, measured by Cu-Kα radiation at room temperature, comprises at least six of diffraction peaks with 2θ values of 6.1±0.2, 8.7±0.2, 10.1±0.2, 11.4±0.2, 12.1±0.2, 12.6±0.2, 14.5±0.2, 17.6±0.2, 18.2±0.2, 20.4±0.2, 22.9±0.2, 24.4±0.2, 25.7±0.2, 28.9±0.2, and 32.1±0.2. The crystal form of prothioconazole has the advantages of excellent stability, simple preparation, and excellent biological activity.

JP3913983	Cyclic hydrazine derivative as a TNF-α inhibitor
WO/2006/103119	TYROSINASE INHIBITORS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND ALSO IN COSMETICS
JPS62265274	DELTA2-1,2,4-TRIAZOLIN-5-ONE DERIVATIVE AND PRODUCTION THEREOF

ZHAO YONGCHANG (CN)
SUN ZIPEI (CN)
LIU MINGJIE (CN)
WANG CHUNHUA (CN)
QIAO ZHEN (CN)
ZHENG YABIN (CN)
PAN JUNXIN (CN)
LI DAN (CN)
LI XINYI (CN)
XIE YAQIONG (CN)
TIAN QINGHAI (CN)
WANG WEIHUA (CN)
CHEN BOYANG (CN)

PCT/CN2019/104442

February 11, 2021

September 04, 2019

Click for automatic bibliography generation  

NUTRICHEM COMPANY LTD (CN)
JIANGSU CHANGLONG AGROCHEMICAL COMPANY LTD (CN)

C07D249/12; A01N43/653

CN108546251A	2018-09-18
CN102083802A	2011-06-01

CHOFN INTELLECTUAL PROPERTY (CN)

View/Download PDF      PDF Help

Previous Patent: WINDOW AIR CONDITIONER

Next Patent: METHOD FOR PREPARING OXIDE THIN FILM TRANSISTOR, AND ARRAY SUBSTRATE